- Filed
- Oct 17, 2017 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2017 · Oct 10, 2017 | 56.81M sh |
| Shares Diluted | Q3 2017 · Sep 9, 2017 | 56.71M sh |
| Shares Diluted | Q3 2017 · Sep 9, 2017 | 56.36M sh |
| Shares Diluted | Q3 2017 · Sep 10, 2016 | 55.67M sh |
| Shares Diluted | Q3 2017 · Sep 10, 2016 | 55.85M sh |
| Stock Repurchased | Q3 2017 · Sep 9, 2017 | $0 |
| Stock Repurchased | Q3 2017 · Sep 10, 2016 | $34.85M |
| Capex | Q3 2017 · Sep 9, 2017 | $43.48M |
| Capex | Q3 2017 · Sep 10, 2016 | $33.52M |
| Operating Cash Flow | Q3 2017 · Sep 9, 2017 | −$641.28M |
| Operating Cash Flow | Q3 2017 · Sep 10, 2016 | −$639.64M |
| Cash And Equivalents | Q3 2017 · Sep 9, 2017 | $304.9M |
| Cash And Equivalents | Q3 2017 · Dec 31, 2016 | $1.01B |
| Cash And Equivalents | Q3 2017 · Sep 10, 2016 | $300.35M |
| Cash And Equivalents | Q3 2017 · Jan 2, 2016 | $914.58M |
| Stockholders Equity | Q3 2017 · Sep 9, 2017 | $823.62M |
| Stockholders Equity | Q3 2017 · Dec 31, 2016 | $788.2M |
| Stockholders Equity | Q3 2017 · Sep 10, 2016 | $764.19M |
| Current Liabilities | Q3 2017 · Sep 9, 2017 | $1.41B |
| Current Liabilities | Q3 2017 · Dec 31, 2016 | $2.17B |
| Current Liabilities | Q3 2017 · Sep 10, 2016 | $916.72M |
| Total Liabilities | Q3 2017 · Sep 9, 2017 | $2.08B |
| Total Liabilities | Q3 2017 · Dec 31, 2016 | $2.8B |
| Total Liabilities | Q3 2017 · Sep 10, 2016 | $1.53B |
| Current Assets | Q3 2017 · Sep 9, 2017 | $1.22B |
| Current Assets | Q3 2017 · Dec 31, 2016 | $2.05B |
| Current Assets | Q3 2017 · Sep 10, 2016 | $901.79M |
| Total Assets | Q3 2017 · Sep 9, 2017 | $2.91B |
| Total Assets | Q3 2017 · Dec 31, 2016 | $3.6B |
| Total Assets | Q3 2017 · Sep 10, 2016 | $2.29B |
| Eps Diluted | Q3 2017 · Sep 9, 2017 | −$0.14 |
| Eps Diluted | Q3 2017 · Sep 9, 2017 | −$0.49 |
| Eps Diluted | Q3 2017 · Sep 10, 2016 | −$0.09 |
| Eps Diluted | Q3 2017 · Sep 10, 2016 | −$0.36 |
| Eps Basic | Q3 2017 · Sep 9, 2017 | −$0.14 |
| Eps Basic | Q3 2017 · Sep 9, 2017 | −$0.49 |
| Eps Basic | Q3 2017 · Sep 10, 2016 | −$0.09 |
| Eps Basic | Q3 2017 · Sep 10, 2016 | −$0.36 |
| Sga Expense | Q3 2017 · Sep 9, 2017 | $24.12M |
| Sga Expense | Q3 2017 · Sep 9, 2017 | $78.71M |
| Sga Expense restated | Q3 2017 · Sep 10, 2016 | $21.77M |
| Sga Expense restated | Q3 2017 · Sep 10, 2016 | $67.83M |
| Net Income | Q3 2017 · Sep 9, 2017 | −$7.77M |
| Net Income | Q3 2017 · Sep 9, 2017 | −$27.6M |
| Net Income | Q3 2017 · Sep 10, 2016 | −$5.1M |
| Net Income | Q3 2017 · Sep 10, 2016 | −$19.99M |
| Operating Income | Q3 2017 · Sep 9, 2017 | −$12.7M |
| Operating Income | Q3 2017 · Sep 9, 2017 | −$34.13M |
| Operating Income | Q3 2017 · Sep 10, 2016 | −$10.09M |
| Operating Income | Q3 2017 · Sep 10, 2016 | −$28.11M |
| Cost Of Revenue | Q3 2017 · Sep 9, 2017 | $37.15M |
| Cost Of Revenue | Q3 2017 · Sep 9, 2017 | $117.88M |
| Cost Of Revenue | Q3 2017 · Sep 10, 2016 | $29.12M |
| Cost Of Revenue | Q3 2017 · Sep 10, 2016 | $103.16M |